Edwards Lifesciences Total Liabilities 2010-2024 | EW

Edwards Lifesciences total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
  • Edwards Lifesciences total liabilities for the quarter ending December 31, 2024 were $2.992B, a 13.19% increase year-over-year.
  • Edwards Lifesciences total liabilities for 2024 were $2.992B, a 13.19% increase from 2023.
  • Edwards Lifesciences total liabilities for 2023 were $2.644B, a 6.36% increase from 2022.
  • Edwards Lifesciences total liabilities for 2022 were $2.486B, a 6.78% decline from 2021.
Edwards Lifesciences Annual Total Liabilities
(Millions of US $)
2024 $2,992
2023 $2,644
2022 $2,486
2021 $2,667
2020 $2,663
2019 $2,340
2018 $2,183
2017 $2,710
2016 $1,891
2015 $1,553
2014 $1,332
2013 $1,166
2012 $742
2011 $643
2010 $459
2009 $458
Edwards Lifesciences Quarterly Total Liabilities
(Millions of US $)
2024-12-31 $2,992
2024-09-30 $3,360
2024-06-30 $2,595
2024-03-31 $2,550
2023-12-31 $2,644
2023-09-30 $2,644
2023-06-30 $2,558
2023-03-31 $2,589
2022-12-31 $2,486
2022-09-30 $2,420
2022-06-30 $2,482
2022-03-31 $2,575
2021-12-31 $2,667
2021-09-30 $2,619
2021-06-30 $2,529
2021-03-31 $2,555
2020-12-31 $2,663
2020-09-30 $2,591
2020-06-30 $2,585
2020-03-31 $2,175
2019-12-31 $2,340
2019-09-30 $2,152
2019-06-30 $2,073
2019-03-31 $2,022
2018-12-31 $2,183
2018-09-30 $2,597
2018-06-30 $2,522
2018-03-31 $2,579
2017-12-31 $2,710
2017-09-30 $2,326
2017-06-30 $2,199
2017-03-31 $2,038
2016-12-31 $1,891
2016-09-30 $1,647
2016-06-30 $1,580
2016-03-31 $1,555
2015-12-31 $1,553
2015-09-30 $1,455
2015-06-30 $1,320
2015-03-31 $1,275
2014-12-31 $1,332
2014-09-30 $1,307
2014-06-30 $1,412
2014-03-31 $1,311
2013-12-31 $1,166
2013-09-30 $1,093
2013-06-30 $760
2013-03-31 $705
2012-12-31 $742
2012-09-30 $660
2012-06-30 $641
2012-03-31 $614
2011-12-31 $643
2011-09-30 $628
2011-06-30 $617
2011-03-31 $573
2010-12-31 $459
2010-09-30 $492
2010-06-30 $524
2010-03-31 $453
2009-12-31 $458
2009-09-30 $512
2009-06-30 $462
2009-03-31 $416
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $42.050B $5.440B
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) United States $171.942B 78.88
Thermo Fisher Scientific (TMO) United States $161.378B 19.56
Alcon (ALC) Switzerland $45.645B 30.34
IDEXX Laboratories (IDXX) United States $33.347B 38.56
DexCom (DXCM) United States $26.887B 41.56
IQVIA Holdings (IQV) United States $25.374B 14.04
STERIS (STE) Ireland $21.834B 24.97
Mettler-Toledo (MTD) United States $20.944B 24.42
Waters (WAT) United States $19.099B 27.04
SONOVA HOLDING (SONVY) Switzerland $17.304B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $13.878B 14.16
Hologic (HOLX) United States $12.916B 13.94
Sysmex ADR (SSMXY) Japan $11.847B 0.00
Penumbra (PEN) United States $10.729B 96.64
Globus Medical (GMED) United States $9.767B 22.61
Masimo (MASI) United States $8.221B 34.50
Teleflex (TFX) United States $6.004B 9.24
Glaukos (GKOS) United States $5.153B 0.00
Integer Holdings (ITGR) United States $4.081B 22.07
TransMedics (TMDX) United States $2.985B 87.37
PROCEPT BioRobotics (PRCT) United States $2.907B 0.00
Veracyte (VCYT) United States $2.427B 43.86
Nihon Kohden (NHNKY) Japan $2.081B 11.37
LivaNova (LIVN) United Kingdom $1.934B 11.74
Elekta AB (EKTAY) Sweden $1.891B 17.00
Alphatec Holdings (ATEC) United States $1.522B 0.00
Integra LifeSciences Holdings (IART) United States $1.222B 6.18
Pulse Biosciences (PLSE) United States $1.193B 0.00
Tandem Diabetes Care (TNDM) United States $1.122B 0.00
Paragon 28 (FNA) United States $1.099B 0.00
Artivion (AORT) United States $0.979B 91.72
OPKO Health (OPK) United States $0.954B 0.00
AxoGen (AXGN) United States $0.690B 0.00
IRadimed (IRMD) United States $0.658B 34.51
Mesa Laboratories (MLAB) United States $0.609B 13.30
SiBone (SIBN) United States $0.588B 0.00
RxSight (RXST) United States $0.584B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.572B 9.21
OrthoPediatrics (KIDS) United States $0.510B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.508B 0.00
Beta Bionics (BBNX) United States $0.483B 0.00
Treace Medical Concepts (TMCI) United States $0.406B 0.00
Delcath Systems (DCTH) United States $0.389B 0.00
AngioDynamics (ANGO) United States $0.387B 0.00
NeuroPace (NPCE) United States $0.351B 0.00
Pacific Biosciences Of California (PACB) United States $0.348B 0.00
ClearPoint Neuro (CLPT) United States $0.342B 0.00
Tactile Systems Technology (TCMD) United States $0.315B 16.87
Semler Scientific (SMLR) United States $0.312B 6.62
Neuronetics (STIM) United States $0.247B 0.00
Inogen (INGN) United States $0.183B 0.00
Alpha Tau Medical (DRTS) Israel $0.181B 0.00
908 Devices (MASS) United States $0.168B 0.00
Spectral Diagnostics (EDTXF) Canada $0.165B 0.00
LENSAR (LNSR) United States $0.164B 0.00
CVRx (CVRX) United States $0.163B 0.00
Accuray (ARAY) United States $0.152B 0.00
Sight Sciences (SGHT) United States $0.137B 0.00
Lucid Diagnostics (LUCD) United States $0.110B 0.00
KORU Medical Systems (KRMD) United States $0.104B 0.00
Rapid Micro Biosystems (RPID) United States $0.104B 0.00
Anteris Technologies Global (AVR) Australia $0.104B 0.00
Monogram Orthopaedics (MGRM) United States $0.095B 0.00
Microbot Medical (MBOT) United States $0.087B 0.00
Atossa Genetics (ATOS) United States $0.080B 0.00
InspireMD (NSPR) Israel $0.079B 0.00
Sensus Healthcare (SRTS) United States $0.076B 11.48
Hyperfine (HYPR) United States $0.054B 0.00
Positron (POSC) United States $0.051B 0.00
EDAP TMS S.A (EDAP) France $0.051B 0.00
EnVVeno Medical (NVNO) United States $0.043B 0.00
Baird Medical Investment Holdings (BDMD) $0.037B 0.00
Vicarious Surgical (RBOT) United States $0.032B 0.00
Spectral AI (MDAI) United States $0.031B 0.00
DarioHealth (DRIO) United States $0.031B 0.00
Precision Optics (POCI) United States $0.030B 0.00
Envoy Medical (COCH) United States $0.029B 0.00
Adagio Medical Holdings (ADGM) United States $0.027B 0.00
NexGel (NXGL) United States $0.022B 0.00
Accelerate Diagnostics (AXDX) United States $0.014B 0.00
PAVmed (PAVM) United States $0.012B 0.00
Ekso Bionics Holdings (EKSO) United States $0.012B 0.00
Biosig Technologies (BSGM) United States $0.010B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.007B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
WORK Medical Technology Group (WOK) China $0.006B 0.00
Nanovibronix (NAOV) United States $0.005B 0.00
Autonomix Medical (AMIX) United States $0.005B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
Check-Cap (CHEK) Israel $0.004B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00